James Stocks, M.D.
NPI 1003197088 · Urology Physician · Cypress, TX
Provider details
- NPI number
- 1003197088
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- R0332 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
14 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
27,347 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Detection Test By Nucleic Acid for Organism, Amplified Probe Technique87798 | 11,375 | $34 |
| Detection Test for Candida Species (yeast), Amplified Probe Technique87481 | 4,009 | $34 |
| Detection Test By Nucleic Acid for Multiple Organisms, Amplified Probe(s) Technique87801 | 2,255 | $66 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,134 | $129 |
| Urinalysis, Manual Test81002 | 995 | $3 |
| Detection Test By Nucleic Acid for Staphylococcus Aureus (bacteria), Amplified Probe Technique87640 | 876 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,046 across 31 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-09-02
- Last updated
- 2023-11-28
- Certified
- 2023-11-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.